These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10333980

  • 1. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
    Horst WD, Preskorn SH.
    J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997 Dec; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

  • 3. New antidepressant drugs and the treatment of depression in the medically ill patient.
    Stoudemire A.
    Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814
    [Abstract] [Full Text] [Related]

  • 4. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Masand PS, Gupta S.
    Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E, Kus K, Bobkiewicz-Kozłowska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    Preskorn SH.
    J Clin Psychiatry; 1995 Sep; 56 Suppl 6():12-21. PubMed ID: 7649968
    [Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 8. Nefazodone and venlafaxine: two new agents for the treatment of depression.
    Goldberg RJ.
    J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
    [Abstract] [Full Text] [Related]

  • 9. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N, Maneeton B, Eurviriyanukul K, Srisurapanont M.
    Drug Des Devel Ther; 2013 Dec; 7():1053-62. PubMed ID: 24101861
    [Abstract] [Full Text] [Related]

  • 10. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR, Nemeroff CB.
    Depress Anxiety; 1998 Dec; 7 Suppl 1():24-32. PubMed ID: 9597349
    [Abstract] [Full Text] [Related]

  • 11. Three new antidepressants.
    Drug Ther Bull; 1996 Sep; 34(9):65-8. PubMed ID: 8885497
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring of non-tricyclic antidepressant drugs.
    Mitchell PB.
    Clin Chem Lab Med; 2004 Sep; 42(11):1212-8. PubMed ID: 15576285
    [Abstract] [Full Text] [Related]

  • 13. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W, Kucia K.
    Wiad Lek; 2007 Sep; 60(1-2):28-33. PubMed ID: 17607965
    [Abstract] [Full Text] [Related]

  • 14. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    Stahl SM.
    J Clin Psychiatry; 1998 Sep; 59 Suppl 4():5-14. PubMed ID: 9554316
    [Abstract] [Full Text] [Related]

  • 15. Antidepressants.
    Frazer A.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract] [Full Text] [Related]

  • 16. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
    Möller HJ, Volz HP.
    Drugs; 1996 Nov; 52(5):625-38. PubMed ID: 9118813
    [Abstract] [Full Text] [Related]

  • 17. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM.
    Lancet; 2000 Mar 11; 355(9207):911-8. PubMed ID: 10752718
    [Abstract] [Full Text] [Related]

  • 18. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N, Ginsberg DL, Bikoff J.
    J Clin Psychiatry; 2001 Apr 11; 62(4):256-60. PubMed ID: 11379839
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH, Emamian ES, Kist DA.
    Ann Pharmacother; 1999 Jun 11; 33(6):701-3. PubMed ID: 10410184
    [Abstract] [Full Text] [Related]

  • 20. [Review of antidepressants from the TCAs to the third generation drugs].
    Almási J, Rihmer Z.
    Neuropsychopharmacol Hung; 2004 Dec 11; 6(4):185-94. PubMed ID: 15825674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.